Plenary Symposiums


Thursday 10.30-12.00 amHall 1

PL-T-1
The surgery smorgasbord - where are we now, where are we going?

Chair(s): Peng Khaw (United Kingdom); Prin Rojanapongpun (Thailand); Ingeborg Stalmans (Belgium);


Friday 10.30-12.00 amHall 1

PL-F-1
Hot debates in glaucoma - in honour of Juhani Airaksinen

Chair(s): Lisandro Sakata (Brazil); Kuldev Singh (United States);

  • 10.30-10.40
    With recent advances in optic nerve imaging, I believe that baseline optic nerve stereo photos are still essential
    George Spaeth (United States)
  • 10.40-10.45
    With recent advances in optic nerve imaging, I believe that baseline optic nerve stereo photos are now unnecessary
    Felipe Medeiros (United States)
  • 10.45-10.50
    In a patient with open angle glaucoma, a concurrent diagnosis of moderate to high myopia: does not fundamentally influence diagnosis and treatment
    Tin Aung (Singapore)
  • 10.50-10.55
    In a patient with open angle glaucoma, a concurrent diagnosis of moderate to high myopia: influences diagnosis but not treatment
    Ki Ho Park (South Korea)
  • 10.55-11.00
    In a patient with open angle glaucoma, a concurrent diagnosis of moderate to high myopia: influences both diagnosis and treatment
    Robert Chang (United States)
  • 11.00-11.05
    In 5 years, the most successful glaucoma drug delivery system will be: extraocular IOP lowering drug delivery
    Jamie Brandt (United States)
  • 11.05-11.10
    In 5 years, the most successful glaucoma drug delivery system will be: intracameral IOP lowering drug delivery
    Ingeborg Stalmans (Belgium)
  • 11.10-11.15
    In 5 years, the most successful glaucoma drug delivery system will be: intravitreal IOP lowering drug delivery
    Uday Kompella (United States)
  • 11.15-11.20
    Non bleb forming MIGS surgery is: a passing FAD
    Robert Weinreb (United States)
  • 11.20-11.25
    Non bleb forming MIGS surgery: is here to stay
    Ike Ahmed (Canada)
  • 11.25-11.30
    In a patient with well controlled mild glaucoma on one IOP lowering medication who requires cataract surgery I generally perform: cataract surgery alone
    Fabian Lerner (Argentina)
  • 11.30-11.35
    In a patient with well controlled mild glaucoma on one IOP lowering medication who requires cataract surgery I generally perform: cataract surgery with a MIGs procedure
    Julian Garcia Feijoo (Spain)
  • 11.35-11.40
    In 5 years, the go to surgical procedure in patients with advanced uncontrolled glaucoma will be trabeculectomy
    Tanuj Dada (India)
  • 11.40-11.45
    In 5 years, the go to surgical procedure in patients with uncontrolled glaucoma will be a bleb forming procedure employing a device
    Syril Dorairaj (United States)
  • 11.45-11.50
    In 5 years, the go to surgical procedure in patients with advanced uncontrolled glaucoma will be a non bleb forming procedure
    Tarek Shaarawy (Switzerland)

Saturday 10.30-11.30 amHall 1

PL-S-1
Grand rounds

Chair(s): Eytan Blumenthal (Israel); David Friedman (United States); Fabian Lerner (Argentina); Tarek Shaarawy (Switzerland);